Apollomics, Inc.
NASDAQ:APLMBiotechnology
+$6.03 today
- Market cap
- $52.00M
- Beta
- 1.45
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$25.98
Volume 0.02M
Average 0.02M
APLM Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Apollomics, Inc.NASDAQ: APLM
Common Stock · Q4 FY2025 · quarter ended Dec 2025
Common stock rises 90.9% from a year ago
Common stock stood at $21K at the end of Q4 FY2025, up 90.9% from a year earlier. Over 3 fiscal years it compounded at -20.0% a year.
Context
- Common stock amounted to 0.3% of total assets at the end of Q4 FY2025, up 0.2 pp from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +90.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 21K USD
- Year-over-year change
- +90.9%
- 4-year CAGR
- -14.9%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21K | +90.9% |
| FY2024 | 2024-12-31 | 11K | +22.2% |
| FY2023 | 2023-12-31 | 9K | -78.0% |
| FY2022 | 2022-12-31 | 41K | +2.5% |
| FY2021 | 2021-12-31 | 40K | — |
Common Stock vs competitors
How APLM compares with its peers on the latest reported figures
- APLM's Dec 2025 common stock of $21K is the highest of the 2 companies compared; the peer median is $12K.
- Its year-over-year change of +90.9% is the highest of 2, against a peer median of +9.1%.
- Common stock amounts to 0.3% of total assets for APLM, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $21K | +90.9% | -20.0% | 0.3% | |
| Dec 2025 | $12K | +9.1% | +44.2% | 0.0% | |
| Peer median (excluding APLM) | $12K | +9.1% | +44.2% | 0.0% | |
Competitors are the stored peer set for APLM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 46.74M | 32.68M | 32.06M | 9.77M | 3.28M |
| Short-term Investments | 47.74M | 21.94M | 5.76M | 0 | 0 |
| Net Receivables | 506K | 547K | 466K | 127K | 2.49M |
| Inventory | 2.26M | 0 | 0 | 0 | 0 |
| Other Current Assets | 120K | 0 | 7K | 0 | 0 |
| Total Current Assets | 99.37M | 55.79M | 39.93M | 10.27M | 6.05M |
| Property, Plant & Equipment (Net) | 1.32M | 1.48M | 586K | 1.02M | 580K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 14.8M | 14.78M | 14.76M | 1.74M | 0 |
| Long-term Investments | 7.84M | 4.31M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 113K | 124K | 119K | 75K | 83K |
| Total Non-current Assets | 24.07M | 20.69M | 15.46M | 2.83M | 663K |
| Total Assets | 123.44M | 76.48M | 55.39M | 13.1M | 6.71M |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 2.16M | 0 | 4.24M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (508K) | 68K | 0 | 0 | 0 |
| Total Current Liabilities | 13.56M | 12.36M | 13.56M | 7.4M | 6.33M |
| Long-term Debt | 322.22M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | (3.62M) | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 3.62M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 322.22M | 511.86M | 330K | 102K | 3.14M |
| Total Non-current Liabilities | 322.74M | 512.24M | 597K | 835K | 3.58M |
| Total Liabilities | 336.3M | 524.6M | 14.15M | 8.23M | 9.9M |
| Common Stock | 40K | 41K | 9K | 11K | 21K |
| Retained Earnings | (235.44M) | (474.6M) | (646.97M) | (700.82M) | (711.76M) |
| Accumulated OCI | 12.29M | 3.4M | 26.72M | 3.44M | 3.44M |
| Other Stockholders Equity | 0 | 10.83M | 0 | 35.71M | 34.73M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (212.86M) | (448.12M) | 41.23M | 4.86M | (3.19M) |
| Total Debt | 325.41M | 991K | 4.66M | 966K | 643K |
| Net Debt | 278.67M | (31.68M) | (27.4M) | (8.8M) | (2.63M) |
Apollomics, Inc.
NASDAQ:APLM
Intrinsic Alpha fair value
Locked
Current Price
$17.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.